metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Giant rectal varix in a patient with portal hypertension
Información de la revista
Vol. 101. Núm. 4.
Páginas 287 (abril 2023)
Vol. 101. Núm. 4.
Páginas 287 (abril 2023)
Image of the month
Acceso a texto completo
Giant rectal varix in a patient with portal hypertension
Variz rectal gigante en paciente con hipertensión portal
Visitas
146
Beatriz Castro Andrés
Autor para correspondencia
bea.ca.93@gmail.com

Corresponding author.
, Jorge Sancho Muriel, Luis Hurtado Pardo, Cristina Martínez Chicote
Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitari y Politècnic La Fe, Valencia, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Descargar PDF
Estadísticas
Figuras (2)
Texto completo

A 46-year-old man with no history of interest except for a non-filial cryptogenic portal cavernomatosis diagnosed in 1994 with an inconclusive biopsy. He first came to our clinic in 2011 for examination for rectorrhagia and sensation of anal mass.

Physical examination revealed grade 1 haemorrhoids that did not justify the symptoms. An MRI was requested to rule out pelvic pathology, which revealed a large varicose dilatation of up to 4 cm extending from the hepatic hilum to the left flank and hypogastrium, which remained unchanged in the last MRI, from which the photographs were obtained (Figs. 1 and 2).

Fig. 1.

Pelvic MRI in axial section with LAVA sequence. The rectum (arrow) and the adjacent rectal varicose vein (asterisk) are visualised.

(0.2MB).
Fig. 2.

Pelvic MRI in coronal section with LAVA sequence. The collapsed rectum (arrow) and adjacent rectal varicose vein (asterisk) are visualised.

(0.15MB).
Copyright © 2022. AEC
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos